Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Genalyte, Inc. is a life sciences company developing and commercializing innovative next-generation multiplexing technology. Genalyte has developed a new approach to immunodetection using silicon chip manufacturing methods. Its Maverick platform uses a technology called silicon photonics to directly measure protein binding between antibodies and antigens or hybridization of nucleic acids.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 11, 2021 | Series Unknown | $50M | 1 | Verily | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Verily | Yes | Series Unknown |